Neurocrine Biosciences
NBIX
#1390
Rank
NZ$21.70 B
Marketcap
$214.37
Share price
-0.13%
Change (1 day)
14.47%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total assets

Total assets on the balance sheet as of September 2024 : NZ$5.96 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total assets are NZ$5.96 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Neurocrine Biosciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31NZ$5.14 B37.81%
2022-12-31NZ$3.73 B22.96%
2021-12-31NZ$3.03 B26.21%
2020-12-31NZ$2.40 B23.98%
2019-12-31NZ$1.93 B30.97%
2018-12-31NZ$1.48 B28.61%
2017-12-31NZ$1.15 B118.42%
2016-12-31NZ$0.52 B-24.02%
2015-12-31NZ$0.69 B123.64%
2014-12-31NZ$0.31 B64.79%
2013-12-31NZ$0.18 B-20.99%
2012-12-31NZ$0.23 B34.37%
2011-12-31NZ$0.17 B-5.29%
2010-12-31NZ$0.18 B92%
2009-12-31NZ$97.5 M-52.12%
2008-12-31NZ$0.20 B-43.61%
2007-12-31NZ$0.36 B-34.7%
2006-12-31NZ$0.55 B-21.75%
2005-12-31NZ$0.70 B-2.86%
2004-12-31NZ$0.72 B-14.77%
2003-12-31NZ$0.85 B67.63%
2002-12-31NZ$0.50 B-38.94%
2001-12-31NZ$0.83 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$4.83 B-19.04%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$30.45 B 410.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$18.13 M-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$127.60 B 2,038.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$242.06 B 3,957.20%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$370.43 B 6,108.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.55 B-73.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.53 M-99.79%๐Ÿ‡บ๐Ÿ‡ธ USA